Back to Results
First PageMeta Content
Health / Pharmaceutical sciences / Drug discovery / Orphan drug / Clinical research / Rare disease / Biologic / Multitier architecture / Orphan Drug Act / Pharmacology / Pharmaceuticals policy / Health economics


August 30, 2013 The Honorable David B. McKinley 412 Cannon House Office Building Washington, DC[removed]Dear Mr. McKinley: On behalf of the 30 million men, women and children in the U.S. affected by the estimated 7,300 kno
Add to Reading List

Document Date: 2013-09-26 15:17:12


Open Document

File Size: 277,88 KB

Share Result on Facebook

City

Washington / DC / /

Country

United States / /

Currency

USD / /

/

Facility

Cannon House Office Building / /

/

IndustryTerm

healthcare costs / co-insurance requirement / orphan products / co-insurance rate / therapies for all rare disorders / /

MedicalCondition

rare diseases / rare disorders / rare disease / /

Organization

National Organization for Rare Disorders / /

/

Position

Peter L. Saltonstall President and CEO / /

ProgrammingLanguage

DC / /

Technology

diagnostic tests / /

SocialTag